243 related articles for article (PubMed ID: 17331859)
1. Regulation of the atherogenic properties of vascular smooth muscle proteoglycans by oral anti-hyperglycemic agents.
de Dios ST; Frontanilla KV; Nigro J; Ballinger ML; Ivey ME; Cawson EA; Little PJ
J Diabetes Complications; 2007; 21(2):108-17. PubMed ID: 17331859
[TBL] [Abstract][Full Text] [Related]
2. Pyrido-pyrimidine derivative CYC10424 inhibits glycosaminoglycan changes on vascular smooth muscle-derived proteoglycans and reduces lipoprotein binding.
Ballinger ML; Osman N; Wilks AF; Su S; Burns CJ; Bu X; Little PJ
J Cardiovasc Pharmacol; 2008 Nov; 52(5):403-12. PubMed ID: 19033819
[TBL] [Abstract][Full Text] [Related]
3. Thrombin regulates vascular smooth muscle cell proteoglycan synthesis via PAR-1 and multiple downstream signalling pathways.
Ivey ME; Little PJ
Thromb Res; 2008; 123(2):288-97. PubMed ID: 18571697
[TBL] [Abstract][Full Text] [Related]
4. Fenofibrate modifies human vascular smooth muscle proteoglycans and reduces lipoprotein binding.
Nigro J; Ballinger ML; Dilley RJ; Jennings GL; Wight TN; Little PJ
Diabetologia; 2004 Dec; 47(12):2105-13. PubMed ID: 15592811
[TBL] [Abstract][Full Text] [Related]
5. Fatty acids cause alterations of human arterial smooth muscle cell proteoglycans that increase the affinity for low-density lipoprotein.
Rodríguez-Lee M; Ostergren-Lundén G; Wallin B; Moses J; Bondjers G; Camejo G
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):130-5. PubMed ID: 16239593
[TBL] [Abstract][Full Text] [Related]
6. Androgens stimulate human vascular smooth muscle cell proteoglycan biosynthesis and increase lipoprotein binding.
Hashimura K; Sudhir K; Nigro J; Ling S; Williams MR; Komesaroff PA; Little PJ
Endocrinology; 2005 Apr; 146(4):2085-90. PubMed ID: 15661861
[TBL] [Abstract][Full Text] [Related]
7. Binding of platelet-derived growth factor and low density lipoproteins to glycosaminoglycan species produced by human arterial smooth muscle cells.
Fager G; Camejo G; Olsson U; Ostergren-Lundén G; Lustig F; Bondjers G
J Cell Physiol; 1995 May; 163(2):380-92. PubMed ID: 7706380
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of Ki11502 as a potent inhibitor of PDGF beta receptor-mediated proteoglycan synthesis in vascular smooth muscle cells.
Getachew R; Ballinger ML; Burch ML; Little PJ; Osman N
Eur J Pharmacol; 2010 Jan; 626(2-3):186-92. PubMed ID: 19818754
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of large proteoglycan synthesis in cultured smooth muscle cells from pig aorta by endothelial cell-conditioned medium.
Berrou E; Breton M; Deudon E; Picard J
J Cell Physiol; 1991 Dec; 149(3):436-43. PubMed ID: 1744172
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylated troglitazone activates PPARgamma and inhibits vascular smooth muscle cell proliferation and proteoglycan synthesis.
Little PJ; Ballinger ML; Survase S; Osman N; Ogru E; Geytenbeek S; Bruemmer D; Nigro J
J Cardiovasc Pharmacol; 2008 Mar; 51(3):274-9. PubMed ID: 18356692
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-1 activates ETA receptors on human vascular smooth muscle cells to yield proteoglycans with increased binding to LDL.
Ballinger ML; Ivey ME; Osman N; Thomas WG; Little PJ
Atherosclerosis; 2009 Aug; 205(2):451-7. PubMed ID: 19217622
[TBL] [Abstract][Full Text] [Related]
12. Smad and p38 MAP kinase-mediated signaling of proteoglycan synthesis in vascular smooth muscle.
Dadlani H; Ballinger ML; Osman N; Getachew R; Little PJ
J Biol Chem; 2008 Mar; 283(12):7844-52. PubMed ID: 18223258
[TBL] [Abstract][Full Text] [Related]
13. Anti-proliferative activity of oral anti-hyperglycemic agents on human vascular smooth muscle cells: thiazolidinediones (glitazones) have enhanced activity under high glucose conditions.
Little PJ; Osman N; de Dios ST; Cemerlang N; Ballinger M; Nigro J
Cardiovasc Diabetol; 2007 Oct; 6():33. PubMed ID: 17963526
[TBL] [Abstract][Full Text] [Related]
14. Thiazolidinediones reduce the LDL binding affinity of non-human primate vascular cell proteoglycans.
Tannock LR; Little PJ; Tsoi C; Barrett PH; Wight TN; Chait A
Diabetologia; 2004 May; 47(5):837-43. PubMed ID: 15071727
[TBL] [Abstract][Full Text] [Related]
15. (S)-[6]-Gingerol inhibits TGF-β-stimulated biglycan synthesis but not glycosaminoglycan hyperelongation in human vascular smooth muscle cells.
Kamato D; Babaahmadi Rezaei H; Getachew R; Thach L; Guidone D; Osman N; Roufogalis B; Duke CC; Tran VH; Zheng W; Little PJ
J Pharm Pharmacol; 2013 Jul; 65(7):1026-36. PubMed ID: 23738730
[TBL] [Abstract][Full Text] [Related]
16. Proteoglycans synthesized by arterial smooth muscle cells in the presence of transforming growth factor-beta1 exhibit increased binding to LDLs.
Little PJ; Tannock L; Olin KL; Chait A; Wight TN
Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):55-60. PubMed ID: 11788461
[TBL] [Abstract][Full Text] [Related]
17. Arterial smooth muscle cell proteoglycans synthesized in the presence of glucosamine demonstrate reduced binding to LDL.
Tannock LR; Little PJ; Wight TN; Chait A
J Lipid Res; 2002 Jan; 43(1):149-57. PubMed ID: 11792734
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1beta selectively decreases the synthesis of versican by arterial smooth muscle cells.
Lemire JM; Chan CK; Bressler S; Miller J; LeBaron RG; Wight TN
J Cell Biochem; 2007 Jun; 101(3):753-66. PubMed ID: 17226775
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived growth factor-stimulated versican synthesis but not glycosaminoglycan elongation in vascular smooth muscle is mediated via Akt phosphorylation.
Osman N; Getachew R; Thach L; Wang H; Su X; Zheng W; Little PJ
Cell Signal; 2014 May; 26(5):912-6. PubMed ID: 24462709
[TBL] [Abstract][Full Text] [Related]
20. Macrophage secretory products selectively stimulate dermatan sulfate proteoglycan production in cultured arterial smooth muscle cells.
Edwards IJ; Wagner WD; Owens RT
Am J Pathol; 1990 Mar; 136(3):609-21. PubMed ID: 2316626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
